Clinical Trial Update: Efficacy and Safety Study of Telbivudine to Prevent Perinatal Transmission [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of telbivudine to prevent mother-to-child transmission of hepatitis B during gestation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Telbivudine (Tyzeka) (telbivudine)

Snippet

Sponsor: Southeast University, China | Conditions: Chronic Hepatitis B, Gestation | Phase 4 | Status: UNKNOWN